INIST ST has carried on the raw material medicine manufacturing as its main business since 2000 and has raw material medicine manufacturing facilities proper for the Global GMP and KGMP regulations.The main API products of INIST include antiviral drug, hyperlipemia drug, antiulcer drug, and genito-urinary medicine. The company provides top-quality finished medicine products domestically and overseas.
As a drive for future corporate growth, INIST carries out CMO (Contract Manufacturing Organization) with multinational drug companies, securing a stable sales structure and financial soundness while improving quality control and technological capacity.
The company has concluded CMO contracts on the raw material medicine for the novel anticancer drugs of lung cancer drug and leukemia drug with domestic and overseas novel drug manufacturers. INIST has also produced raw material medicine for overseas clinical tests and drug release.